190 related articles for article (PubMed ID: 31937595)
1. Guidance Document: Validation of a High-Performance Liquid Chromatography-Tandem Mass Spectrometry Immunopeptidomics Assay for the Identification of HLA Class I Ligands Suitable for Pharmaceutical Therapies.
Ghosh M; Gauger M; Marcu A; Nelde A; Denk M; Schuster H; Rammensee HG; Stevanović S
Mol Cell Proteomics; 2020 Mar; 19(3):432-443. PubMed ID: 31937595
[TBL] [Abstract][Full Text] [Related]
2. Sensitive Immunopeptidomics by Leveraging Available Large-Scale Multi-HLA Spectral Libraries, Data-Independent Acquisition, and MS/MS Prediction.
Pak H; Michaux J; Huber F; Chong C; Stevenson BJ; Müller M; Coukos G; Bassani-Sternberg M
Mol Cell Proteomics; 2021; 20():100080. PubMed ID: 33845167
[TBL] [Abstract][Full Text] [Related]
3. Benchmarking Bioinformatics Pipelines in Data-Independent Acquisition Mass Spectrometry for Immunopeptidomics.
Shahbazy M; Ramarathinam SH; Illing PT; Jappe EC; Faridi P; Croft NP; Purcell AW
Mol Cell Proteomics; 2023 Apr; 22(4):100515. PubMed ID: 36796644
[TBL] [Abstract][Full Text] [Related]
4. Sensitive, High-Throughput HLA-I and HLA-II Immunopeptidomics Using Parallel Accumulation-Serial Fragmentation Mass Spectrometry.
Phulphagar KM; Ctortecka C; Jacome ASV; Klaeger S; Verzani EK; Hernandez GM; Udeshi ND; Clauser KR; Abelin JG; Carr SA
Mol Cell Proteomics; 2023 Jun; 22(6):100563. PubMed ID: 37142057
[TBL] [Abstract][Full Text] [Related]
5. FASTMAP-a flexible and scalable immunopeptidomics pipeline for HLA- and antigen-specific T-cell epitope mapping based on artificial antigen-presenting cells.
Weisbrod L; Capriotti L; Hofmann M; Spieler V; Dersch H; Voedisch B; Schmidt P; Knake S
Front Immunol; 2024; 15():1386160. PubMed ID: 38779658
[TBL] [Abstract][Full Text] [Related]
6. Soluble HLA peptidome of pleural effusions is a valuable source for tumor antigens.
Khazan-Kost S; Cafri G; Melamed Kadosh D; Mooshayef N; Chatterji S; Dominissini D; Manor S; Zisser B; Broday L; Talalai E; Shemer A; Zadok O; Ofek E; Onn A; Admon A; Peled M
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580925
[TBL] [Abstract][Full Text] [Related]
7. Biogenesis of HLA Ligand Presentation in Immune Cells Upon Activation Reveals Changes in Peptide Length Preference.
Marino F; Semilietof A; Michaux J; Pak HS; Coukos G; Müller M; Bassani-Sternberg M
Front Immunol; 2020; 11():1981. PubMed ID: 32983136
[TBL] [Abstract][Full Text] [Related]
8. Identification of Immunodominant HIV-1 Epitopes Presented by HLA-C*12:02, a Protective Allele, Using an Immunopeptidomics Approach.
Chikata T; Paes W; Akahoshi T; Partridge T; Murakoshi H; Gatanaga H; Ternette N; Oka S; Borrow P; Takiguchi M
J Virol; 2019 Sep; 93(17):. PubMed ID: 31217245
[TBL] [Abstract][Full Text] [Related]
9. Deep learning boosts sensitivity of mass spectrometry-based immunopeptidomics.
Wilhelm M; Zolg DP; Graber M; Gessulat S; Schmidt T; Schnatbaum K; Schwencke-Westphal C; Seifert P; de Andrade Krätzig N; Zerweck J; Knaute T; Bräunlein E; Samaras P; Lautenbacher L; Klaeger S; Wenschuh H; Rad R; Delanghe B; Huhmer A; Carr SA; Clauser KR; Krackhardt AM; Reimer U; Kuster B
Nat Commun; 2021 Jun; 12(1):3346. PubMed ID: 34099720
[TBL] [Abstract][Full Text] [Related]
10. Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung Adenocarcinoma.
Qi YA; Maity TK; Cultraro CM; Misra V; Zhang X; Ade C; Gao S; Milewski D; Nguyen KD; Ebrahimabadi MH; Hanada KI; Khan J; Sahinalp C; Yang JC; Guha U
Mol Cell Proteomics; 2021; 20():100136. PubMed ID: 34391887
[TBL] [Abstract][Full Text] [Related]
11. Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry.
Freudenmann LK; Marcu A; Stevanović S
Immunology; 2018 Jul; 154(3):331-345. PubMed ID: 29658117
[TBL] [Abstract][Full Text] [Related]
12. Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows.
Partridge T; Nicastri A; Kliszczak AE; Yindom LM; Kessler BM; Ternette N; Borrow P
Front Immunol; 2018; 9():912. PubMed ID: 29780384
[TBL] [Abstract][Full Text] [Related]
13. High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome.
Chong C; Marino F; Pak H; Racle J; Daniel RT; Müller M; Gfeller D; Coukos G; Bassani-Sternberg M
Mol Cell Proteomics; 2018 Mar; 17(3):533-548. PubMed ID: 29242379
[TBL] [Abstract][Full Text] [Related]
14. Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS/MS.
Hofmann S; Glückmann M; Kausche S; Schmidt A; Corvey C; Lichtenfels R; Huber C; Albrecht C; Karas M; Herr W
Mol Cell Proteomics; 2005 Dec; 4(12):1888-97. PubMed ID: 16112985
[TBL] [Abstract][Full Text] [Related]
15. Optimized Liquid and Gas Phase Fractionation Increases HLA-Peptidome Coverage for Primary Cell and Tissue Samples.
Klaeger S; Apffel A; Clauser KR; Sarkizova S; Oliveira G; Rachimi S; Le PM; Tarren A; Chea V; Abelin JG; Braun DA; Ott PA; Keshishian H; Hacohen N; Keskin DB; Wu CJ; Carr SA
Mol Cell Proteomics; 2021; 20():100133. PubMed ID: 34391888
[TBL] [Abstract][Full Text] [Related]
16. Cyclin-dependent kinaselike 5 is a novel target of immunotherapy in adult T-cell leukemia.
Kawahara M; Hori T; Matsubara Y; Okawa K; Uchiyama T
J Immunother; 2007; 30(5):499-505. PubMed ID: 17589290
[TBL] [Abstract][Full Text] [Related]
17. Acid Stripping after Infection Improves the Detection of Viral HLA Class I Natural Ligands Identified by Mass Spectrometry.
Lorente E; Marcilla M; de la Sota PG; Quijada-Freire A; Mir C; López D
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638844
[TBL] [Abstract][Full Text] [Related]
18. Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells.
Yaciuk JC; Skaley M; Bardet W; Schafer F; Mojsilovic D; Cate S; Stewart CJ; McMurtrey C; Jackson KW; Buchli R; Olvera A; Cedeño S; Plana M; Mothe B; Brander C; West JT; Hildebrand WH
J Virol; 2014 Nov; 88(22):12992-3004. PubMed ID: 25165114
[TBL] [Abstract][Full Text] [Related]
19. High-Throughput, Fast, and Sensitive Immunopeptidomics Sample Processing for Mass Spectrometry.
Marino F; Chong C; Michaux J; Bassani-Sternberg M
Methods Mol Biol; 2019; 1913():67-79. PubMed ID: 30666599
[TBL] [Abstract][Full Text] [Related]
20. HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy.
Marcu A; Bichmann L; Kuchenbecker L; Kowalewski DJ; Freudenmann LK; Backert L; Mühlenbruch L; Szolek A; Lübke M; Wagner P; Engler T; Matovina S; Wang J; Hauri-Hohl M; Martin R; Kapolou K; Walz JS; Velz J; Moch H; Regli L; Silginer M; Weller M; Löffler MW; Erhard F; Schlosser A; Kohlbacher O; Stevanović S; Rammensee HG; Neidert MC
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33858848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
